ABOUT INOVAIL

Inovail Holdings Pte Ltd is a newly-formed specialty pharmaceutical company focused on market-driven innovation in the Asia Pacific Region.

Our therapeutic areas of focus are in dermatology, complementary oncology and female healthcare. Inovail specialises in value-added sales, marketing and formulation development activities of high potential in-licensed products and acquired existing brands in our targeted therapeutic fields.

We at Inovail see ourselves as experts in Asia Pacific and believe that we are the ideal partner to the international specialty pharmaceutical industry, bringing their products to prominence in Asia Pacific.

Inovail Holdings Pte Ltd is a newly-formed specialty pharmaceutical company focusing on market-driven innovation in the Asia Pacific Region.

Our areas of specialty are in primary care, dermatology and female healthcare. Within these areas, Inovail’s experienced teams are able to integrate capabilities ranging from market feasibility studies, regulatory affairs, marketing management, medical affairs. Our growth strategy is focused on driving innovation in the Asia Pacific Region.

Our activities range from in-licensing of innovative compounds to acquisition of existing brands. Inovail sees itself as a partner for the R&D based pharmaceutical industry that supports the refocusing of companies on their core businesses by assuming full responsibilities for various business areas, either by acquisition or in-licensing. Companies with investments in dermatology, complementary oncology and female healthcare will find value in our strategic partnership.

With the breadth of our services and the depth of our regional knowledge, we are the ideal strategic partner to bring your products to prominence in Asia Pacific.